Nirsevimab sharply cuts RSV hospitalizations in U.S. infants during the 2024–2025 season
Real-world data confirm that nirsevimab provides powerful protection for infants, reducing RSV hospital stays and easing the strain…
Browsing Tag
Respiratory syncytial virus
1 post